Read the evidence, with context.
Sixteen reference entries. Primary sources, study conditions and explicit unknowns.
- BPC-157
BPC 157
Investigated in a rat medial collateral ligament injury model.
Animal study - TB-500
TB500
An analytical study identified an acetylated seven-amino-acid fragment in TB-500.
Identity study - CJC-1295 DAC
Long-acting albumin-binding CJC-1295
Two placebo-controlled studies examined prolonged GH and IGF-I responses in healthy adults.
Human study - Ipamorelin
Ipamorelin (distinguish salt and formulation)
A pharmacokinetic study measured ipamorelin and GH responses during intravenous infusion in healthy men.
Human study - GHK-Cu
Copper-bound GHK
GHK-Cu was studied for collagen synthesis in fibroblast cultures.
Cell study - MOTS-c
Mitochondrial open reading frame of the 12S rRNA-c
The discovery study described a mitochondrial-derived peptide and metabolic effects in cells and mice.
Animal study - Epitalon
Epithalon
A cell-culture experiment investigated telomerase activity and telomere length in human fetal fibroblasts.
Cell study - Semax
ACTH(4–7)-Pro-Gly-Pro
An experiment examined gene expression after focal cerebral ischemia in rats.
Animal study - Selank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
A 62-patient study compared Selank with medazepam using anxiety scales and biological measures.
Human study - AOD-9604
AOD9604
A developer-associated publication summarized safety observations from six human clinical trials.
Human study - DSIP
Delta sleep-inducing peptide
An early double-blind crossover experiment studied sleep responses in six healthy volunteers.
Human study - KPV
Lys-Pro-Val
A study examined peptide transport and inflammatory signaling in cells and mouse colitis models.
Animal study - LL-37
Cathelicidin LL-37
A 148-patient trial tested topical LL-37 with compression therapy for venous leg ulcers.
Human study - Melanotan II
Melanotan-II
A three-volunteer phase-I pilot examined pigmentation and adverse effects of a cyclic melanotropic peptide.
Human study - GHRP-2
Growth hormone-releasing peptide-2
A diagnostic study evaluated GH responses to intravenous GHRP-2 in healthy participants and patients.
Human study - GHRP-6
Growth hormone-releasing peptide-6
A phase-I study modeled intravenous GHRP-6 disposition in nine healthy male volunteers.
Human study
No matching reference. Try another name or clear the search.
“Human study” describes the source, not a safety endorsement. A study-specific half-life is not a dosing interval. These entries do not recommend doses or product storage instructions.